How big is Sabra Health Care REIT, Inc.?

As of Jun 18, Sabra Health Care REIT, Inc. has a market capitalization of $4.32 billion, with net sales of $714.38 million and a net profit of $140.77 million over the latest four quarters. The company reported shareholder's funds of $2.74 billion and total assets of $5.30 billion as of Dec 24.

Market Cap: As of Jun 18, Sabra Health Care REIT, Inc. has a market capitalization of 4,316.17 million, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Sabra Health Care REIT, Inc. reported net sales of 714.38 million and a net profit of 140.77 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 2,741.29 million and total assets of 5,303.68 million.

What does Sabra Health Care REIT, Inc. do?

Sabra Health Care REIT, Inc. is a real estate investment trust focused on healthcare properties, with a market cap of approximately $4.32 billion. As of March 2025, it reported net sales of $186 million and a net profit of $40 million.

Overview: <BR>Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in real estate serving the healthcare industry, operating within the Realty sector and classified as a small-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 186 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 40 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 4,316.17 Million (Small Cap)<BR><BR>Key Metrics: <BR>P/E: 27.00 <BR>Dividend Yield: 642.84% <BR>Debt Equity: -999,999.00 <BR>Return on Equity: 5.78% <BR>Price to Book: 1.60<BR><BR>Contact Details: <BR>Address: 18500 von Karman Ave Ste 550, IRVINE CA : 92612-0539 <BR>Tel: 1 888 3938248 <BR>Fax: 1 949 6798868 <BR>Website: http://www.sabrahealth.com/

Should I buy, sell or hold Sabra Health Care REIT, Inc.?

Who are in the management team of Sabra Health Care REIT, Inc.?

As of March 2022, the management team of Sabra Health Care REIT, Inc. includes Chairman and CEO Richard Matros, Lead Independent Director Michael Foster, Directors Katie Cusack, Ann Kono, Clifton Porter, and Independent Director Craig Barbarosh, who oversee the company's operations and strategy.

As of March 2022, the management team of Sabra Health Care REIT, Inc. includes the following individuals:<BR><BR>- Mr. Richard Matros serves as the Chairman of the Board, President, and Chief Executive Officer.<BR>- Mr. Michael Foster is the Lead Independent Director.<BR>- Ms. Katie Cusack, Ms. Ann Kono, and Mr. Clifton Porter are Directors.<BR>- Mr. Craig Barbarosh serves as an Independent Director. <BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Is Sabra Health Care REIT, Inc. overvalued or undervalued?

As of February 27, 2024, Sabra Health Care REIT, Inc. has improved its valuation grade to very attractive, appearing undervalued with favorable P/E, PEG, and EV to EBITDA ratios compared to peers, despite a recent short-term decline in stock performance.

As of 27 February 2024, the valuation grade for Sabra Health Care REIT, Inc. has moved from risky to very attractive, indicating a significant improvement in its investment appeal. The company appears undervalued, supported by a P/E ratio of 27, a PEG ratio of 0.18, and an EV to EBITDA ratio of 9.20, which are favorable compared to its peers. For instance, Vornado Realty Trust has a P/E of 9.71, and Rithm Capital Corp. has an EV to EBITDA of 1.61, highlighting Sabra's relative valuation strength.<BR><BR>Despite the recent stock performance showing a 1-week decline of 1.41% compared to the S&P 500's gain of 1.05%, the longer-term outlook remains promising with a year-to-date return of 8.89% against the S&P 500's 12.22%. This suggests that while the stock has faced short-term challenges, its overall valuation metrics indicate it is positioned well for future growth.

Is Sabra Health Care REIT, Inc. technically bullish or bearish?

As of October 31, 2025, Sabra Health Care REIT, Inc. shows a mildly bullish trend despite mixed technical indicators and has underperformed the S&P 500 with a year-to-date return of 3.81% compared to 16.30%.

As of 31 October 2025, the technical trend for Sabra Health Care REIT, Inc. has changed from sideways to mildly bullish. The daily moving averages indicate a mildly bullish stance, while the weekly and monthly MACD and KST are both mildly bearish. The Bollinger Bands show a bullish signal on the monthly timeframe but are mildly bearish weekly. Overall, the indicators present a mixed picture, leaning towards a mild bullish sentiment.<BR><BR>In terms of performance, the stock has underperformed the S&P 500 across multiple periods, with a year-to-date return of 3.81% compared to the S&P 500's 16.30%, and a one-year return of -3.54% versus 19.89% for the benchmark.